Fragment Molecular Orbital Drug Design Consortium (FMODD): Bridging Academia and Industry Through Prospective FMO-Driven Drug Design

Alexander Heifetz, Kaori Fukuzawa

Open source

DOI
10.1007/978-1-0716-5420-0_19
Published
2026
Container
Methods in Molecular Biology
Publisher
Springer US
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/978-1-0716-5420-0_19,
  title = {Fragment Molecular Orbital Drug Design Consortium (FMODD): Bridging Academia and Industry Through Prospective FMO-Driven Drug Design},
  author = {Alexander Heifetz and Kaori Fukuzawa},
  year = {2026},
  journal = {Methods in Molecular Biology},
  doi = {10.1007/978-1-0716-5420-0_19},
  url = {https://doi.org/10.1007/978-1-0716-5420-0_19}
}

RIS

TY  - JOUR
TI  - Fragment Molecular Orbital Drug Design Consortium (FMODD): Bridging Academia and Industry Through Prospective FMO-Driven Drug Design
AU  - Alexander Heifetz
AU  - Kaori Fukuzawa
PY  - 2026
JO  - Methods in Molecular Biology
DO  - 10.1007/978-1-0716-5420-0_19
UR  - https://doi.org/10.1007/978-1-0716-5420-0_19
ER  - 

APA

Heifetz, A., & Fukuzawa, K. (2026). Fragment Molecular Orbital Drug Design Consortium (FMODD): Bridging Academia and Industry Through Prospective FMO-Driven Drug Design. Methods in Molecular Biology. https://doi.org/10.1007/978-1-0716-5420-0_19

Source records